Search

Author/Creator Patterson, Terrell A.

1. Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study. (12th November 2020)

Authors:
Damy, Thibaud; Garcia‐Pavia, Pablo; Hanna, Mazen; Judge, Daniel P.; Merlini, Giampaolo; Gundapaneni, Balarama; Patterson, Terrell A.; Riley, Steven; Schwartz, Jeffrey H.; Sultan, Marla B.; Witteles, Ronald
Journal:
European journal of heart failure
Issue:
Volume 23:Number 2(2021)
Page Start:
277
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. The Bioequivalence of Tafamidis 61‐mg Free Acid Capsules and Tafamidis Meglumine 4 × 20‐mg Capsules in Healthy Volunteers. Issue 7 (20th March 2020)

Authors:
Lockwood, Peter A.; Le, Vu H.; O'Gorman, Melissa T.; Patterson, Terrell A.; Sultan, Marla B.; Tankisheva, Ekaterina; Wang, Qiang; Riley, Steve
Journal:
Clinical pharmacology in drug development
Issue:
Volume 9:Issue 7(2020)
Page Start:
849
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗